Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Villar

Showing results (601-610 of 623) with videos related to

Pageof 63
Sort By:
Revista De Neurologia|September 7, 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)O Fernandez, C Arnal-Garcia, R Arroyo-Gonzalez, et al.
International Journal of Environmental Research and Public Health|July 31, 2019
Evaluation of HBV-Like Circulation in Wild and Farm Animals from Brazil and UruguayYasmine R Vieira, Moyra M Portilho, Flávia F Oliveira, et al.
Brain : a Journal of Neurology|April 14, 2020
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.
The European Respiratory Journal|April 3, 2012
European union standards for tuberculosis careG B Migliori, J P Zellweger, I Abubakar, et al.
Journal of Neurology|December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosisManuel Comabella, Harald Hegen, Luisa M Villar, et al.
Frontiers in Immunology|April 7, 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis PathologyJosé I Fernández-Velasco, Enric Monreal, Jens Kuhle, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis DiagnosisManuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Neurologia|October 4, 2022
Consensus statement on the use of alemtuzumab in daily clinical practice in SpainJ E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2019
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter studyC E Leurs, Ham Twaalfhoven, B I Lissenberg-Witte, et al.
Pageof 63

Showing results (601-610 of 623) with videos related to

Sort By:
Pageof 63
Revista De Neurologia|September 7, 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)O Fernandez, C Arnal-Garcia, R Arroyo-Gonzalez, et al.
International Journal of Environmental Research and Public Health|July 31, 2019
Evaluation of HBV-Like Circulation in Wild and Farm Animals from Brazil and UruguayYasmine R Vieira, Moyra M Portilho, Flávia F Oliveira, et al.
Brain : a Journal of Neurology|April 14, 2020
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.
The European Respiratory Journal|April 3, 2012
European union standards for tuberculosis careG B Migliori, J P Zellweger, I Abubakar, et al.
Journal of Neurology|December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosisManuel Comabella, Harald Hegen, Luisa M Villar, et al.
Frontiers in Immunology|April 7, 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis PathologyJosé I Fernández-Velasco, Enric Monreal, Jens Kuhle, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis DiagnosisManuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Neurologia|October 4, 2022
Consensus statement on the use of alemtuzumab in daily clinical practice in SpainJ E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2019
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter studyC E Leurs, Ham Twaalfhoven, B I Lissenberg-Witte, et al.
Pageof 63